Rang	Name	Position
1	Dr. Ying Du Ph.D.	Founder, Chairperson & CEO
2	Dr. Rafael G. Amado M.D.	President and Head of Global Research & Development
3	Dr. Yajing Chen Ph.D.	Chief Financial Officer
4	Mr. Frazor Titus Edmondson III, J.D.	Chief Legal Officer & Corporate Secretary
5	Ms. Christine Chiou	Senior VP & Head of Investor Relations
6	Dr. James Yan DABT, M.D., Ph.D.	Chief Operating Officer of Global R&D
7	Dr. Shan He Ph.D.	Senior VP & Chief Business Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RTW INVESTMENTS, LLC	5,86%	0,16 Mrd. USD
2	TCG Crossover Management, LLC	5,47%	0,15 Mrd. USD
3	RA Capital Management, LLC	5,08%	0,14 Mrd. USD
4	Frazier Life Sciences Management, L.P.	1,69%	0,05 Mrd. USD
5	BAMCO Inc	1,48%	0,04 Mrd. USD
6	ADAR1 Capital Management LLC	1,27%	0,03 Mrd. USD
7	Two Sigma Investments LLC	1,16%	0,03 Mrd. USD
8	Citadel Advisors Llc	1,14%	0,03 Mrd. USD
9	FMR Inc	1,12%	0,03 Mrd. USD
10	BlackRock Inc	0,77%	0,02 Mrd. USD
11	Rock Springs Capital Management LP	0,73%	0,02 Mrd. USD
12	CAM Group Holding A/S	0,45%	0,01 Mrd. USD
13	UBS Group AG	0,45%	0,01 Mrd. USD
14	B Group, Inc	0,40%	0,01 Mrd. USD
15	Schroder Investment Management Group	0,35%	0,01 Mrd. USD
16	NAN FUNG TRINITY (HK) Ltd	0,31%	0,01 Mrd. USD
17	Aberdeen Group PLC	0,28%	0,01 Mrd. USD
18	T. Rowe Price Associates, Inc.	0,26%	0,01 Mrd. USD
19	Spruce Street Capital LP	0,25%	0,01 Mrd. USD
20	Jane Street Group LLC	0,24%	0,01 Mrd. USD